FDF China,collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the integration of science and technology with economic growth and increase the sharing of innovation results.   New pharmaceutical industry structure, new high ground through innovation The newly revised dr

As a world-renowned vertical trade and exchange event of the pharmaceutical industry, CPhI & P-MEC China 2020will take place at Shanghai New International Expo Centre (SNIEC) June 22-24, 2020. The exhibition will reach a scale of 210,000m2,facilitate over 3,400 Chinese and overseas exhibitors to showcase innovative products and advanced technologies, and jointly unlock a grand gala of the pharmaceutical industry with over 75,000 professional visits from more than 140 countries and regions

To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry--- bioLIVE China 2020, will be held again at Hall W4 in the SNIEC on June 22-24, 2020. The exhibition, co-located with CPhI China 2020, will build an international trade platform of information sharing and business cooperation for professionals from sectors of biopharmaceuticals, biotechnology, new drug R&D, and pharmaceutical investment, e

Global procurement management of pharmaceutical packaging materials has become a hot issue that all pharmaceutical enterprises are facing under the economic globalization. Rational packaging procurement will not only help to achieve the balance between functionality and cost but also prevent shortsupply. Therefore, how to efficiently obtain accurate information on potential suppliers appears to be particularly important.

AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., totake place at the Shanghai New International Expo Centre on June 22-24, 2020 together with CPhI & P-MEC China 2020, will focus on automatic production, information system layout, network security, and the new trend of safety and lean manufacturing of the phar

P-MEC China, co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets,will take place at the Shanghai New International Expo Center (SNIEC) on 22-24 June 2020. The event will be co-located with CPhI China with total area exceeding 210,000m2 and over 75,000 visits of professionals are expected. P-MEC China unveiled as a co-locate of CPhI China with the rising

Polaryx Therapeutics, a biotech company developing patient-friendly small molecule therapeutics for lysosomal storage disorders announced today that the Company has received an Investigational New Drug Application (IND) approval from the U.S. Food and Drug Administration (FDA) for the treatment of LINCL patients with PLX-200. Neuronal Ceroid Lipofuscinoses are a group of rare autosomal recessive neurodegenerative lysosomal storage disorders. Among them, LINCL is caused by mutations

Syndivia, a biotechnology company focused on the development of new therapeutic modalities for solid cancers based on specific targeting of the tumor microenvironment and anatomical hallmarks, announced today that it has been granted an exclusive, worldwide sublicense by SATT Sud-Est to the immunoconjugates of the anti?CD146-ts antibody (excluding diagnosis), which binds a tumor-specific form of CD146 found on a number of solid cancers. CD146-ts has a central role in the mechanism of tumorige

ANI Pharmaceuticals, Inc. announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Potassium Citrate Extended-Release Tablets USP, 10 mEq and 15 mEq.  The current annual U.S. market for this product is approximately $75 million, according to IQVIA. Arthur S. Przybyl, ANI's President and CEO stated, "We are excited to receive FDA approval for this extended release drug that was s

Syntegon Technology is the new name among the market leaders in the processing and packaging industry. Known as Bosch Packaging Technology until late 2019, the former Bosch division today presented itself as an independent enterprise at the company headquarters inWaiblingen (Germany). Syntegon Technology’s business focus is on intelligent and sustainable technologies for the pharmaceutical and food industries. Extending the service range is a priority for the company. Syntegon Technolog